Clinical Trial Update: A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of gemcitabine plus nab-paclitaxel with or without FG-3019 in locally advanced, unresectable pancreatic cancer has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FG-3019 (fresolimumab)
• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Kyntra Bio | Conditions: Pancreatic Cancer (Unresectable) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-03-02